AdvanSix Announces Fourth Quarter and Full Year 2023 Financial Results
4Q23 Sales of
4Q23 Earnings Per Share of (
4Q23 Cash Flow from Operations of
Returned
Full Year 2023 Summary
- Sales down 21% versus prior year driven by 17% unfavorable impact of market-based pricing and 5% lower raw material pass-through pricing, partially offset by 1% contribution from acquisitions and flat volume
-
Net Income of
$54.6 million , a decrease of$117.3 million versus the prior year -
Adjusted EBITDA of
$153.6 million , a decrease of$154.9 million versus the prior year -
Cash Flow from Operations of
$117.6 million , a decrease of$156.1 million versus the prior year -
Capital Expenditures of
$107.4 million , an increase of$17.9 million versus the prior year -
Free Cash Flow of
$10.2 million , a decrease of$174.0 million versus the prior year -
Repurchased 1,317,402 shares for approximately
$46.2 million in 2023
Summary full year 2023 financial results for the Company are included below:
($ in Thousands, Except Earnings Per Share) |
FY 2023 |
|
FY 2022 |
Sales |
|
|
|
Net Income |
54,623 |
|
171,886 |
Diluted Earnings Per Share |
|
|
|
Adjusted Diluted Earnings Per Share (1) |
|
|
|
Adjusted EBITDA (1) |
153,559 |
|
308,481 |
Adjusted EBITDA Margin % (1) |
10.0% |
|
15.9% |
Cash Flow from Operations |
117,550 |
|
273,601 |
Free Cash Flow (1)(2) |
10,173 |
|
184,152 |
(1) See “Non-GAAP Measures” included in this press release for non-GAAP reconciliations |
(2) Net cash provided by operating activities less capital expenditures |
“I'm proud of the team and our continued commitment to driving improved through-cycle profitability. Our healthy balance sheet helped to support our performance through challenging market conditions, particularly in Nylon Solutions, while maintaining organic investments and return of cash to our shareholders,” said
Fourth Quarter 2023 Summary
- Sales down 5% versus prior year driven by 22% unfavorable impact of market-based pricing, partially offset by a 16% increase in volume and 1% higher raw materials pass-through pricing.
-
Net Loss of
($5.1) million , a decrease of$38.7 million versus the prior year -
Adjusted EBITDA of
$15.1 million , a decrease of$51.5 million versus the prior year -
Cash Flow from Operations of
$60.2 million , a decrease of$9.4 million versus the prior year -
Capital Expenditures of
$38.4 million , an increase of$9.9 million versus the prior year -
Free Cash Flow of
$21.8 million , a decrease of$19.4 million versus the prior year -
Repurchased 306,527 shares for approximately
$8.5 million in 4Q23
Summary fourth quarter 2023 financial results for the Company are included below:
($ in Thousands, Except Earnings Per Share) |
4Q 2023 |
|
4Q 2022 |
Sales |
|
|
|
Net Income (Loss) |
(5,082) |
|
33,625 |
Diluted Earnings Per Share |
( |
|
|
Adjusted Diluted Earnings Per Share (1) |
( |
|
|
Adjusted EBITDA (1) |
15,099 |
|
66,580 |
Adjusted EBITDA Margin % (1) |
4.0% |
|
16.5% |
Cash Flow from Operations |
60,169 |
|
69,614 |
Free Cash Flow (1)(2) |
21,817 |
|
41,175 |
(1) See “Non-GAAP Measures” included in this press release for non-GAAP reconciliations |
(2) Net cash provided by operating activities less capital expenditures |
Sales of
Sales by product line and approximate percentage of total sales are included below:
($ in Thousands) |
FY 2023 |
|
FY 2022 |
||||||
|
Sales |
|
% of Total |
|
Sales |
|
% of Total |
||
Nylon |
$ |
356,632 |
|
23% |
|
$ |
485,241 |
|
25% |
Caprolactam |
|
298,375 |
|
19% |
|
|
319,863 |
|
16% |
Ammonium Sulfate |
|
440,915 |
|
29% |
|
|
629,021 |
|
33% |
Chemical Intermediates |
|
437,677 |
|
29% |
|
|
511,515 |
|
26% |
|
$ |
1,533,599 |
|
100% |
|
$ |
1,945,640 |
|
100% |
($ in Thousands) |
4Q 2023 |
|
4Q 2022 |
||||||
|
Sales |
|
% of Total |
|
Sales |
|
% of Total |
||
Nylon |
$ |
78,251 |
|
20% |
|
$ |
93,510 |
|
23% |
Caprolactam |
|
82,508 |
|
22% |
|
|
71,871 |
|
18% |
Ammonium Sulfate |
|
108,691 |
|
28% |
|
|
136,734 |
|
34% |
Chemical Intermediates |
|
112,759 |
|
30% |
|
|
101,947 |
|
25% |
|
$ |
382,209 |
|
100% |
|
$ |
404,062 |
|
100% |
Adjusted EBITDA of
Adjusted earnings per share of (
Cash flow from operations of
Dividend
The Company's Board of Directors declared a quarterly cash dividend of
Outlook
- Expect nylon industry spreads to remain stabilized near current levels amid weak demand; Anticipate higher Nylon Solutions exports in first half of 2024 year-over-year
- Anticipate strong ammonium sulfate seasonal demand supported by continued favorable underlying agriculture industry fundamentals; Expect first half 2024 year-over-year pricing declines amid lower nitrogen pricing environment
- Expect balanced to tight global acetone supply and demand conditions
-
Expect Capital Expenditures of
$140 to$150 million in 2024, reflecting increased spend to address critical enterprise risk mitigation and growth projects including our SUSTAIN program -
Expect pre-tax income impact of planned plant turnarounds to be
$38 to$43 million in 2024 versus approximately$30 million in 2023 -
Now expect to incur a total unfavorable impact to pre-tax income in 1Q24 of
$23 to$27 million as a result of the process-based operational disruption at our Frankford, PA manufacturing site and a delayed ramp to planned utilization rates
"While the previously disclosed operational disruption at our Frankford,
Conference Call Information
About
Forward Looking Statements
This release contains certain statements that may be deemed “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical fact, that address activities, events or developments that our management intends, expects, projects, believes or anticipates will or may occur in the future are forward-looking statements. Forward-looking statements may be identified by words such as "expect," "anticipate," "estimate," “outlook,” "project," "strategy," "intend," "plan," "target," "goal," "may," "will," "should" and "believe" and other variations or similar terminology and expressions. Although we believe forward-looking statements are based upon reasonable assumptions, such statements involve known and unknown risks, uncertainties and other factors, many of which are beyond our control and difficult to predict, which may cause the actual results or performance of the Company to be materially different from any future results or performance expressed or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to: general economic and financial conditions in the
Non-GAAP Financial Measures
This press release includes certain non-GAAP financial measures intended to supplement, not to act as substitutes for, comparable GAAP measures. Reconciliations of non-GAAP financial measures to GAAP financial measures are provided in this press release. Investors are urged to consider carefully the comparable GAAP measures and the reconciliations to those measures provided. Non-GAAP measures in this press release may be calculated in a way that is not comparable to similarly-titled measures reported by other companies.
Consolidated Balance Sheets (Unaudited) (Dollars in thousands, except share and per share amounts) |
|||||||
|
|
|
|
||||
ASSETS |
|
|
|
||||
Current assets: |
|
|
|
||||
Cash and cash equivalents |
$ |
29,768 |
|
|
$ |
30,985 |
|
Accounts and other receivables – net |
|
165,393 |
|
|
|
175,429 |
|
Inventories – net |
|
211,831 |
|
|
|
215,502 |
|
Taxes receivable |
|
1,434 |
|
|
|
9,771 |
|
Other current assets |
|
11,378 |
|
|
|
9,241 |
|
Total current assets |
|
419,804 |
|
|
|
440,928 |
|
|
|
|
|
||||
Property, plant and equipment – net |
|
852,642 |
|
|
|
811,065 |
|
Operating lease right-of-use assets |
|
95,805 |
|
|
|
114,688 |
|
|
|
56,192 |
|
|
|
56,192 |
|
Intangible assets |
|
46,193 |
|
|
|
49,242 |
|
Other assets |
|
25,384 |
|
|
|
23,216 |
|
Total assets |
$ |
1,496,020 |
|
|
$ |
1,495,331 |
|
|
|
|
|
||||
LIABILITIES |
|
|
|
||||
Current liabilities: |
|
|
|
||||
Accounts payable |
$ |
259,068 |
|
|
$ |
272,740 |
|
Accrued liabilities |
|
44,086 |
|
|
|
48,820 |
|
Income taxes payable |
|
8,033 |
|
|
|
30 |
|
Operating lease liabilities – short-term |
|
32,053 |
|
|
|
37,472 |
|
Deferred income and customer advances |
|
15,678 |
|
|
|
34,430 |
|
Total current liabilities |
|
358,918 |
|
|
|
393,492 |
|
|
|
|
|
||||
Deferred income taxes |
|
151,059 |
|
|
|
160,409 |
|
Operating lease liabilities – long-term |
|
63,961 |
|
|
|
77,571 |
|
Line of credit – long-term |
|
170,000 |
|
|
|
115,000 |
|
Postretirement benefit obligations |
|
3,660 |
|
|
|
— |
|
Other liabilities |
|
9,185 |
|
|
|
10,679 |
|
Total liabilities |
|
756,783 |
|
|
|
757,151 |
|
|
|
|
|
||||
STOCKHOLDERS' EQUITY |
|
|
|
||||
Common stock, par value |
|
326 |
|
|
|
320 |
|
Preferred stock, par value |
|
— |
|
|
|
— |
|
|
|
(58 |
) |
|
|
(45 |
) |
Additional paid-in capital |
|
138,046 |
|
|
|
174,585 |
|
Retained earnings |
|
605,067 |
|
|
|
567,517 |
|
Accumulated other comprehensive loss |
|
(4,144 |
) |
|
|
(4,197 |
) |
Total stockholders' equity |
|
739,237 |
|
|
|
738,180 |
|
Total liabilities and stockholders' equity |
$ |
1,496,020 |
|
|
$ |
1,495,331 |
|
Consolidated Statements of Operations (Unaudited) (Dollars in thousands, except share and per share amounts) |
|||||||||||||||
|
Three Months Ended
|
|
Twelve Months Ended
|
||||||||||||
|
|
2023 |
|
|
|
2022 |
|
|
|
2023 |
|
|
|
2022 |
|
Sales |
$ |
382,208 |
|
|
$ |
404,062 |
|
|
$ |
1,533,599 |
|
|
$ |
1,945,640 |
|
|
|
|
|
|
|
|
|
||||||||
Costs, expenses and other: |
|
|
|
|
|
|
|
||||||||
Costs of goods sold |
|
363,667 |
|
|
|
335,033 |
|
|
|
1,368,511 |
|
|
|
1,631,161 |
|
Selling, general and administrative expenses |
|
24,828 |
|
|
|
22,628 |
|
|
|
95,538 |
|
|
|
87,748 |
|
Interest expense, net |
|
2,189 |
|
|
|
763 |
|
|
|
7,485 |
|
|
|
2,781 |
|
Other non-operating (income) expense, net |
|
(240 |
) |
|
|
(16 |
) |
|
|
(7,158 |
) |
|
|
(1,841 |
) |
Total costs, expenses and other |
|
390,444 |
|
|
|
358,408 |
|
|
|
1,464,376 |
|
|
|
1,719,849 |
|
|
|
|
|
|
|
|
|
||||||||
Income (loss) before taxes |
|
(8,236 |
) |
|
|
45,654 |
|
|
|
69,223 |
|
|
|
225,791 |
|
Income tax expense (benefit) |
|
(3,154 |
) |
|
|
12,029 |
|
|
|
14,600 |
|
|
|
53,905 |
|
Net Income (loss) |
$ |
(5,082 |
) |
|
$ |
33,625 |
|
|
$ |
54,623 |
|
|
$ |
171,886 |
|
|
|
|
|
|
|
|
|
||||||||
Earnings per common share |
|
|
|
|
|
|
|
||||||||
Basic |
$ |
(0.19 |
) |
|
$ |
1.22 |
|
|
$ |
2.00 |
|
|
$ |
6.15 |
|
Diluted |
$ |
(0.19 |
) |
|
$ |
1.18 |
|
|
$ |
1.95 |
|
|
$ |
5.92 |
|
|
|
|
|
|
|
|
|
||||||||
Weighted average common shares outstanding |
|
|
|
|
|
|
|
||||||||
Basic |
|
26,911,754 |
|
|
|
27,572,344 |
|
|
|
27,302,254 |
|
|
|
27,969,436 |
|
Diluted |
|
26,911,754 |
|
|
|
28,608,181 |
|
|
|
28,007,630 |
|
|
|
29,031,107 |
|
Consolidated Statements of Cash Flows (Unaudited) (Dollars in thousands) |
|||||||||||||||
|
Three Months Ended
|
|
Twelve Months Ended
|
||||||||||||
|
|
2023 |
|
|
|
2022 |
|
|
|
2023 |
|
|
|
2022 |
|
Cash flows from operating activities: |
|
|
|
|
|
|
|
||||||||
Net income (loss) |
$ |
(5,082 |
) |
|
$ |
33,625 |
|
|
$ |
54,623 |
|
|
$ |
171,886 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
|
|
|
||||||||
Depreciation and amortization |
|
18,673 |
|
|
|
17,483 |
|
|
|
73,010 |
|
|
|
69,353 |
|
Loss on disposal of assets |
|
342 |
|
|
|
218 |
|
|
|
1,281 |
|
|
|
1,521 |
|
Deferred income taxes |
|
(10,416 |
) |
|
|
7,532 |
|
|
|
(9,347 |
) |
|
|
16,228 |
|
Stock-based compensation |
|
2,473 |
|
|
|
2,680 |
|
|
|
8,313 |
|
|
|
10,279 |
|
Amortization of deferred financing fees |
|
154 |
|
|
|
154 |
|
|
|
618 |
|
|
|
618 |
|
Operational asset adjustments |
|
— |
|
|
|
— |
|
|
|
(4,472 |
) |
|
|
— |
|
Changes in assets and liabilities, net of business acquisitions: |
|
|
|
|
|
|
|
||||||||
Accounts and other receivables |
|
(20,696 |
) |
|
|
10,496 |
|
|
|
21,489 |
|
|
|
17,842 |
|
Inventories |
|
17,368 |
|
|
|
(57,070 |
) |
|
|
3,286 |
|
|
|
(57,043 |
) |
Taxes receivable |
|
64 |
|
|
|
5,159 |
|
|
|
8,337 |
|
|
|
(8,824 |
) |
Accounts payable |
|
27,231 |
|
|
|
22,094 |
|
|
|
(20,756 |
) |
|
|
55,863 |
|
Income taxes payable |
|
8,003 |
|
|
|
(9,693 |
) |
|
|
8,003 |
|
|
|
(9,693 |
) |
Accrued liabilities |
|
2,218 |
|
|
|
4,544 |
|
|
|
(5,569 |
) |
|
|
(3,122 |
) |
Deferred income and customer advances |
|
13,263 |
|
|
|
31,869 |
|
|
|
(18,752 |
) |
|
|
31,681 |
|
Other assets and liabilities |
|
6,574 |
|
|
|
523 |
|
|
|
(2,514 |
) |
|
|
(22,988 |
) |
Net cash provided by operating activities |
|
60,169 |
|
|
|
69,614 |
|
|
|
117,550 |
|
|
|
273,601 |
|
|
|
|
|
|
|
|
|
||||||||
Cash flows from investing activities: |
|
|
|
|
|
|
|
||||||||
Expenditures for property, plant and equipment |
|
(38,352 |
) |
|
|
(28,439 |
) |
|
|
(107,377 |
) |
|
|
(89,449 |
) |
Acquisition of businesses |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(97,456 |
) |
Other investing activities |
|
(1,116 |
) |
|
|
(781 |
) |
|
|
(3,520 |
) |
|
|
(2,368 |
) |
Net cash used for investing activities |
|
(39,468 |
) |
|
|
(29,220 |
) |
|
|
(110,897 |
) |
|
|
(189,273 |
) |
|
|
|
|
|
|
|
|
||||||||
Cash flows from financing activities: |
|
|
|
|
|
|
|
||||||||
Borrowings from line of credit |
|
66,000 |
|
|
|
80,500 |
|
|
|
437,000 |
|
|
|
434,500 |
|
Payments of line of credit |
|
(66,000 |
) |
|
|
(100,500 |
) |
|
|
(382,000 |
) |
|
|
(454,500 |
) |
Principal payments of finance leases |
|
(240 |
) |
|
|
(214 |
) |
|
|
(938 |
) |
|
|
(926 |
) |
Dividend payments |
|
(4,303 |
) |
|
|
(3,990 |
) |
|
|
(16,657 |
) |
|
|
(15,073 |
) |
Purchase of treasury stock |
|
(8,500 |
) |
|
|
(10,157 |
) |
|
|
(46,151 |
) |
|
|
(33,748 |
) |
Issuance of common stock |
|
— |
|
|
|
258 |
|
|
|
876 |
|
|
|
1,304 |
|
Net cash used for financing activities |
|
(13,043 |
) |
|
|
(34,103 |
) |
|
|
(7,870 |
) |
|
|
(68,443 |
) |
|
|
|
|
|
|
|
|
||||||||
Net change in cash and cash equivalents |
|
7,658 |
|
|
|
6,291 |
|
|
|
(1,217 |
) |
|
|
15,885 |
|
Cash and cash equivalents at beginning of year |
|
22,110 |
|
|
|
24,694 |
|
|
|
30,985 |
|
|
|
15,100 |
|
Cash and cash equivalents at the end of year |
$ |
29,768 |
|
|
$ |
30,985 |
|
|
$ |
29,768 |
|
|
$ |
30,985 |
|
|
|
|
|
|
|
|
|
||||||||
Supplemental non-cash investing activities: |
|
|
|
|
|
|
|
||||||||
Capital expenditures included in accounts payable |
|
|
|
|
$ |
22,660 |
|
|
$ |
14,879 |
|
Non-GAAP Measures (Dollars in thousands, except share and per share amounts)
Reconciliation of Net Cash Provided by Operating Activities to Free Cash Flow |
|||||||||||||||
|
Three Months Ended
|
|
Twelve Months Ended
|
||||||||||||
|
|
2023 |
|
|
|
2022 |
|
|
|
2023 |
|
|
|
2022 |
|
Net cash provided by operating activities |
$ |
60,169 |
|
|
$ |
69,614 |
|
|
$ |
117,550 |
|
|
$ |
273,601 |
|
Expenditures for property, plant and equipment |
|
(38,352 |
) |
|
|
(28,439 |
) |
|
|
(107,377 |
) |
|
|
(89,449 |
) |
Free cash flow (1) |
$ |
21,817 |
|
|
$ |
41,175 |
|
|
$ |
10,173 |
|
|
$ |
184,152 |
|
|
|
|
|
|
|
|
|
||||||||
(1) Free cash flow is a non-GAAP measure defined as Net cash provided by operating activities less Expenditures for property, plant and equipment |
The Company believes that this metric is useful to investors and management as a measure to evaluate our ability to generate cash flow from business operations and the impact that this cash flow has on our liquidity.
Reconciliation of Net Income to Adjusted EBITDA and Earnings Per Share to Adjusted Earnings Per Share |
|||||||||||||||
|
Three Months Ended
|
|
Twelve Months Ended
|
||||||||||||
|
|
2023 |
|
|
|
2022 |
|
|
|
2023 |
|
|
|
2022 |
|
Net Income (loss) |
$ |
(5,082 |
) |
|
$ |
33,625 |
|
|
$ |
54,623 |
|
|
$ |
171,886 |
|
Non-cash stock-based compensation |
|
2,473 |
|
|
|
2,680 |
|
|
|
8,313 |
|
|
|
10,279 |
|
Non-recurring, unusual or extraordinary expenses (income) (2) |
|
— |
|
|
|
— |
|
|
|
(4,472 |
) |
|
|
— |
|
Non-cash amortization from acquisitions |
|
530 |
|
|
|
532 |
|
|
|
2,126 |
|
|
|
1,815 |
|
Non-recurring M&A costs |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
277 |
|
Benefit from income taxes relating to reconciling items |
|
(504 |
) |
|
|
(535 |
) |
|
|
(661 |
) |
|
|
(1,996 |
) |
Adjusted Net Income (loss) |
|
(2,583 |
) |
|
|
36,302 |
|
|
|
59,929 |
|
|
|
182,261 |
|
Interest expense, net |
|
2,189 |
|
|
|
763 |
|
|
|
7,485 |
|
|
|
2,781 |
|
Income tax expense (benefit) - Adjusted |
|
(2,650 |
) |
|
|
12,564 |
|
|
|
15,261 |
|
|
|
55,901 |
|
Depreciation and amortization - Adjusted |
|
18,143 |
|
|
|
16,951 |
|
|
|
70,884 |
|
|
|
67,538 |
|
Adjusted EBITDA |
$ |
15,099 |
|
|
$ |
66,580 |
|
|
$ |
153,559 |
|
|
$ |
308,481 |
|
|
|
|
|
|
|
|
|
||||||||
Sales |
$ |
382,208 |
|
|
$ |
404,062 |
|
|
$ |
1,533,599 |
|
|
$ |
1,945,640 |
|
|
|
|
|
|
|
|
|
||||||||
Adjusted EBITDA Margin (3) |
|
4.0 |
% |
|
|
16.5 |
% |
|
|
10.0 |
% |
|
|
15.9 |
% |
|
|
|
|
|
|
|
|
||||||||
(2) Includes a pre-tax gain of approximately |
|||||||||||||||
(3) Adjusted EBITDA Margin is defined as Adjusted EBITDA divided by Sales |
|
Three Months Ended
|
|
Twelve Months Ended
|
|||||||||
|
|
2023 |
|
|
|
2022 |
|
|
2023 |
|
|
2022 |
Net Income (loss) |
$ |
(5,082 |
) |
|
$ |
33,625 |
|
$ |
54,623 |
|
$ |
171,886 |
Adjusted Net Income (loss) |
|
(2,583 |
) |
|
|
36,302 |
|
|
59,929 |
|
|
182,261 |
|
|
|
|
|
|
|
|
|||||
Weighted-average number of common shares outstanding - basic |
|
26,911,754 |
|
|
|
27,572,344 |
|
|
27,302,254 |
|
|
27,969,436 |
Dilutive effect of equity awards and other stock-based holdings |
|
— |
|
|
|
1,035,837 |
|
|
705,376 |
|
|
1,061,671 |
Weighted-average number of common shares outstanding - diluted |
|
26,911,754 |
|
|
|
28,608,181 |
|
|
28,007,630 |
|
|
29,031,107 |
|
|
|
|
|
|
|
|
|||||
EPS - Basic |
$ |
(0.19 |
) |
|
$ |
1.22 |
|
$ |
2.00 |
|
$ |
6.15 |
EPS - Diluted |
$ |
(0.19 |
) |
|
$ |
1.18 |
|
$ |
1.95 |
|
$ |
5.92 |
Adjusted EPS - Basic |
$ |
(0.10 |
) |
|
$ |
1.32 |
|
$ |
2.20 |
|
$ |
6.52 |
Adjusted EPS - Diluted |
$ |
(0.10 |
) |
|
$ |
1.27 |
|
$ |
2.14 |
|
$ |
6.28 |
|
|
|
|
|
|
|
|
The Company believes the non-GAAP financial measures presented in this release provide meaningful supplemental information as they are used by the Company’s management to evaluate the Company’s operating performance, enhance a reader’s understanding of the financial performance of the Company, and facilitate a better comparison among fiscal periods and performance relative to its competitors, as these non-GAAP measures exclude items that are not considered core to the Company’s operations.
Appendix (Pre-tax income impact, Dollars in millions)
Planned Plant Turnaround Schedule (4) |
||||||
|
1Q |
2Q |
3Q |
4Q |
FY |
Primary Unit Operation |
2017 |
— |
|
|
|
|
Sulfuric Acid |
2018 |
|
|
|
— |
|
Ammonia |
2019 |
— |
|
|
|
|
Sulfuric Acid |
2020 |
|
|
|
|
|
Ammonia |
2021 |
|
|
— |
|
|
Sulfuric Acid |
2022 |
|
|
|
— |
|
Ammonia |
2023 |
|
|
|
— |
|
Sulfuric Acid |
2024E |
|
— |
|
|
|
Ammonia |
(4) Primarily reflects the impact of fixed cost absorption, maintenance expense, and the purchase of feedstocks which are normally manufactured by the Company. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20240215530378/en/
Media
(973) 526-1615
janeen.lawlor@advansix.com
Investors
(973) 526-1700
adam.kressel@advansix.com
Source: